Morgan Stanley Starts TD Ameritrade (AMTD) at Equalweight
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Morgan Stanley earlier initiated coverage on TD Ameritrade (NASDAQ: AMTD) with an Equalweight rating and a price target of $34.00.
Shares of TD Ameritrade closed at $33.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Ameritrade (AMTD) Reports In-Line Q1 EPS
- RBC Capital Starts Verisk Analytics (VRSK) at Sector Perform
- TD Ameritrade (AMTD) volatility increases into Q1 and outlook
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!